Identification of a founder haplotype of APOE Kyoto variant in lipoprotein glomerulopathy

脂蛋白肾小球病中APOE京都变异体创始单倍型的鉴定

阅读:4
作者:Hongyan Wu,Zhaoxia He,Jing Yang,Yi Zhou,Zhi Yang,Zhangxue Hu,Yuan Yang

Abstract

Background: Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant inherited kidney disease with incomplete penetrance, characterized by nephrotic-range proteinuria, hypertriglyceridemia and progressive renal dysfunction with elevated serum apoE level. More than 15 APOE mutations have been associated with LPG, with APOE Kyoto (Arg43Cys) the leading mutation in about 200 patients. We previously observed clustering of "APOE Kyoto causing LPG" in a Han population in China. We now explore the haplotype of the APOE Kyoto heterozygotes and the distribution of LPG patients in China. Methods: A total of 115 APOE Kyoto heterozygotes were enrolled and identified by Sanger sequencing, and in this study, the haplotypes of Kyoto and counterpart alleles were investigated by TA cloning and Sanger sequencing. Results: Overall, 114 out of 115 APOE Kyoto alleles shared an identical haplotype, likely from haplotype 1 in ε3. Among heterozygotes, the counterpart of APOE Kyoto allele showed haplotype diversity, and the difference in haplotype distribution of the counterpart allele was not observed between LPG patients and asymptomatic carriers. Conclusions: This study provides further evidence for the founder effect of APOE Kyoto may play a critical role in the progression of LPG.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。